The Global Market for High Content Screening (HCS) is Projected to Reach US$837 Million by 2020
Growth in the Number of New Drug Discovery Initiatives
Drives the High Content Screening (HCS) Market, According to a New Report by Global Industry Analysts, Inc.
GIA launches comprehensive analysis of
industry segments, trends, growth drivers, market share, size and demand
forecasts on the global High Content Screening (HCS) market. The
global market for High Content Screening (HCS) is projected to reach US$837 million by 2020, driven by the growing focus on cell-based
research, growth in the number of new drug discovery initiatives, and the introduction
of advanced image analysis instruments.
High content screening (HCS), defined as
the application of high content functional analysis for screening of large
molecule libraries for phenotypic effects on living cells, combines the ability
of cellular imaging with the efficiency of high throughput techniques for
collecting quantitative data from complex biological systems. HCS systems
comprise imaging-based multi-parametric analysis at the single-cell level, and
enable large-scale, rapid, quantitative assessment of cellular and molecular
biology procedures. The technology is used to analyze phenotypic changes in
various cellular samples. The global market is witnessing rapid growth driven
by growing government support to carryout cell-based research activities,
demand for advanced technologies to perform cell analysis, development of
advanced informatics solutions, growing demand for advanced screening systems
and effective purification protocols, and the emergence of innovative
instruments designed for image analysis. Increasing number of toxicity studies
and the focus of research companies on studying the toxicity levels in initial
drug discovery stages is driving the adoption of HCS technology. Also,
increasing government support for life sciences research is encouraging market
growth.
Other factors driving growth in the
market include the growing need to develop new drug molecules, and rising demand
for advanced cell-based
imaging with a focus on cell aggregation, cell structure, and
complex morphological analysis. Technology advancements, such as automated screening
systems for analyzing the cell stability & separation, are also
spearheading growth in the market.
As stated by the new
market research report on High
Content Screening, the United States represents the largest
regional market worldwide. Asia-Pacific is forecast to emerge as the fastest
growing market with a CAGR of 13.8% over the analysis period, led by the growing
number of biotechnology establishments and contract research organizations in
China and India, government initiatives in several Asian countries to support
the development of advanced screening technologies, and emphasis of major
research companies on outsourcing their drug discovery services to low cost
Asian countries.
Major players covered in
the report include BD Biosciences, BioTek Instruments Inc., Definiens AG, EMD
Millipore, EVOTEC BioSystems, Evotec AG, Essen BioScience, Fluxion Biosciences,
Inc., GE Healthcare Life Sciences, Genedata AG, IntelliCyt Corporation,
Molecular Devices Inc., PerkinElmer Inc., Roche Applied Sciences, Thermo Fisher
Scientific, Inc., TTP LabTech Ltd., and Yokogawa Electric Corporation, among
others.
The
research report titled “High
Content Screening (HCS): A Global Strategic Business Report” announced by
Global Industry Analysts Inc., provides a comprehensive review of market
trends, growth drivers, product innovations and strategic industry activities
of major companies worldwide. The report provides market estimates and projections
for sales of High Content Screening in US$ Million at the Manufacturer’s levels
for all major geographic markets - US, Canada, Japan, Europe (France, Germany, Italy,
UK, Spain, and Rest of Europe), Asia-Pacific, and Rest of World. The global market
for High Content Screening is also analyzed by segment – Consumables,
Instruments, and Others (Includes
Software and Services).
Global Industry Analysts, Inc. 6150 Hellyer
Ave., San Jose CA 95138, USA, All Rights Reserved.
Comments
Post a Comment